1-(2-phenylpyrimidin-4-yl)ethanone结构式
|
常用名 | 1-(2-phenylpyrimidin-4-yl)ethanone | 英文名 | 1-(2-phenylpyrimidin-4-yl)ethanone |
|---|---|---|---|---|
| CAS号 | 89967-15-7 | 分子量 | 198.22100 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C12H10N2O | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 1-(2-phenylpyrimidin-4-yl)ethanone |
|---|
| 分子式 | C12H10N2O |
|---|---|
| 分子量 | 198.22100 |
| 精确质量 | 198.07900 |
| PSA | 42.85000 |
| LogP | 2.34620 |
| 海关编码 | 2933599090 |
|---|
|
~62%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
|
~%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
|
~%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
|
~%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
|
~%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
|
~%
1-(2-phenylpyri... 89967-15-7 |
| 文献：Sakamoto, Takao; Sakasai, Takeji; Yoshizawa, Hiroshi; Tanji, Ken-Ichi; Nishimura, Sumiko; Yamanaka, Hiroshi Chemical & Pharmaceutical Bulletin, 1983 , vol. 31, # 12 p. 4554 - 4560 |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
